US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

1.130
+0.010+0.89%

Trading Jul 9 13:21 ET

28.44MMarket Cap-753P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-60.62%55.18K

22.61%55.18K

-15.08%140.11K

6.65%95.1K

Operating revenue

--0

-58.40%55.18K

--0

47.00%55.18K

-0.96%132.64K

--0

16.52%95.1K

Cost of revenue

Gross profit

Operating expense

-17.17%4.38M

24.51%22.31M

-3.38%4.41M

2.82%4.89M

46.66%7.73M

58.54%5.28M

28.06%17.92M

40.26%4.56M

1.88%4.75M

46.28%5.27M

Selling and administrative expenses

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

48.56%2.69M

-General and administrative expense

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

27.43%2.79M

48.56%2.69M

Research and development costs

-10.19%2.51M

37.52%11.52M

4.40%2.37M

20.50%2.37M

54.44%3.99M

79.33%2.79M

16.93%8.38M

54.42%2.27M

-20.67%1.96M

43.98%2.58M

Operating profit

16.29%-4.38M

-25.18%-22.25M

3.38%-4.41M

-2.82%-4.89M

-49.35%-7.73M

-59.03%-5.23M

-28.58%-17.78M

-42.15%-4.56M

-2.48%-4.75M

-47.28%-5.18M

Net non-operating interest income expense

-24.16%115.3K

31.67%494.23K

-35.11%106.27K

-30.87%106K

116.91%129.93K

9,308.66%152.04K

2,904.06%375.36K

61,239.70%163.78K

3,017.77%153.33K

915.07%59.9K

Non-operating interest income

----

31.67%494.23K

----

116.91%129.93K

----

--375.36K

----

--59.9K

Total other finance cost

24.16%-115.3K

----

30.87%-106K

----

-9,308.66%-152.04K

----

-3,017.77%-153.33K

----

Other net income (expense)

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

190.63%40.21K

Gain on sale of security

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

258.66%43.49K

190.63%40.21K

Income before tax

21.99%-3.99M

-26.81%-22.19M

-2.46%-4.71M

-3.13%-4.7M

-50.93%-7.66M

-56.55%-5.12M

-26.00%-17.5M

-42.38%-4.6M

2.24%-4.55M

-42.87%-5.08M

Income tax

18.81%19.87K

-14.74%79.28K

-81.43%14.5K

430.04%21.46K

190.72%26.59K

897.50%16.73K

2,219.76%92.98K

1,047.42%78.11K

-20.84%4.05K

149.89%9.15K

Net income

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

Net income continuous Operations

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

Minority interest income

Net income attributable to the parent company

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

2.26%-4.56M

-42.98%-5.09M

Basic earnings per share

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

-43.33%-0.43

Diluted earnings per share

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

2.56%-0.38

-43.33%-0.43

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-60.62%55.18K	0	0	0	22.61%55.18K	-15.08%140.11K	0	0	6.65%95.1K
Operating revenue	--0	-58.40%55.18K	--0	--0	--0	47.00%55.18K	-0.96%132.64K	--0	--0	16.52%95.1K
Cost of revenue
Gross profit
Operating expense	-17.17%4.38M	24.51%22.31M	-3.38%4.41M	2.82%4.89M	46.66%7.73M	58.54%5.28M	28.06%17.92M	40.26%4.56M	1.88%4.75M	46.28%5.27M
Selling and administrative expenses	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M	48.56%2.69M
-General and administrative expense	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M	27.43%2.79M	48.56%2.69M
Research and development costs	-10.19%2.51M	37.52%11.52M	4.40%2.37M	20.50%2.37M	54.44%3.99M	79.33%2.79M	16.93%8.38M	54.42%2.27M	-20.67%1.96M	43.98%2.58M
Operating profit	16.29%-4.38M	-25.18%-22.25M	3.38%-4.41M	-2.82%-4.89M	-49.35%-7.73M	-59.03%-5.23M	-28.58%-17.78M	-42.15%-4.56M	-2.48%-4.75M	-47.28%-5.18M
Net non-operating interest income expense	-24.16%115.3K	31.67%494.23K	-35.11%106.27K	-30.87%106K	116.91%129.93K	9,308.66%152.04K	2,904.06%375.36K	61,239.70%163.78K	3,017.77%153.33K	915.07%59.9K
Non-operating interest income	----	31.67%494.23K	----	----	116.91%129.93K	----	--375.36K	----	----	--59.9K
Total other finance cost	24.16%-115.3K	----	----	30.87%-106K	----	-9,308.66%-152.04K	----	----	-3,017.77%-153.33K	----
Other net income (expense)	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K	190.63%40.21K
Gain on sale of security	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K	258.66%43.49K	190.63%40.21K
Income before tax	21.99%-3.99M	-26.81%-22.19M	-2.46%-4.71M	-3.13%-4.7M	-50.93%-7.66M	-56.55%-5.12M	-26.00%-17.5M	-42.38%-4.6M	2.24%-4.55M	-42.87%-5.08M
Income tax	18.81%19.87K	-14.74%79.28K	-81.43%14.5K	430.04%21.46K	190.72%26.59K	897.50%16.73K	2,219.76%92.98K	1,047.42%78.11K	-20.84%4.05K	149.89%9.15K
Net income	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M
Net income continuous Operations	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M
Minority interest income
Net income attributable to the parent company	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M	2.26%-4.56M	-42.98%-5.09M
Basic earnings per share	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38	-43.33%-0.43
Diluted earnings per share	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39	2.56%-0.38	-43.33%-0.43
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall